New study could help decide whether chelation benefits the heart

Chelation therapy has long been scorned by many in the medical community. But after a major study suggested it was somewhat effective for heart disease, the alternative health treatment is once again going under the microscope. A second study called TACT 2 (Trial to Assess Chelation Therapy) will assess chelation’s heart-health benefits for patients with diabetes.

Watch the video and read the full story.

Free info session on diabetes, heart disease, and TACT2

TACT2 investigator Dr. Richard Nahas will present a free information session on diabetes, heart disease, and the TACT2 study on Tuesday, February 13, 7:00–8:30 p.m., at Ben Franklin Place in Ottawa, ON. RSVP required. Contact 613.727.7246 or trials@seekerscentre.com for more information.

Listen to Dr. Nahas talk about the history, goals, and significance of TACT2 in the video below.